Overview
What is Prostate Cancer Research Inc?
Prostate Cancer Research Inc, established in September 2020, is a dedicated nonprofit organization based in Dover, Delaware. Their primary mission is to revolutionize the prostate cancer treatment landscape by investing in groundbreaking research and medical advancements. They aim to become the leading authority in prostate cancer research and strengthen their credibility within the scientific community. To achieve this, they form partnerships with various sectors, including the government, pharmaceutical industry, and those affected by prostate cancer. The organization also assembles a team of experts and fosters a culture of continuous learning, with the ultimate goal of creating sustainable growth through strategic funding and grant acquisitions. Prostate Cancer Research Inc's primary focus is to improve the classification and prediction of advanced prostate cancer treatments for individual patients and discover new therapies for advanced stages of the disease.
Official website here: www.pcrus.org
Is Prostate Cancer Research Inc legitimate?
Prostate Cancer Research Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Prostate Cancer Research Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $114,378
For more financial information, click here
Official website here: www.pcrus.org
What is the mission statement of Prostate Cancer Research Inc?
Prostate Cancer Research Inc, established in September 2020, is a non-profit organization dedicated to advancing prostate cancer research and treatments. Their mission is to become a leading authority in the field, strengthening their credibility and reputation among researchers. They aim to forge partnerships with various sectors, including the scientific community, government, pharmaceutical industry, and those affected by prostate cancer. The organization assembles a team of experts to manage their research charity effectively and foster a culture of continuous learning. They strive for sustainable growth by competing for larger grants and strategically investing funds for flexible funding. Their ultimate goal is to deliver breakthrough medicines and treatments, aiming for a world free from the impact of prostate cancer.
Official website here: www.pcrus.org
What is the revenue of Prostate Cancer Research Inc?
Prostate Cancer Research Inc's revenue in 2023 was $22,687.
Official website here: www.pcrus.org
Who are the executives of Prostate Cancer Research Inc and what are their salaries?
The average compensation at Prostate Cancer Research Inc during 2023 was $38,126. There are 3 employees at Prostate Cancer Research Inc.
Here are 9 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.pcrus.org
Where can I find the form 990 for Prostate Cancer Research Inc?
Prostate Cancer Research Inc's most recent form 990 was submitted in 2023 and can be accessed here.
Official website here: www.pcrus.org
Learn more at the official website: www.pcrus.org
Mission Statement of Prostate Cancer Research Inc
Prostate Cancer Research Inc, established in September 2020, is a non-profit organization with a mission to revolutionize the treatment and understanding of prostate cancer. Their objective is to spearhead the development and delivery of groundbreaking medicines, aiming for a world where individuals are liberated from the impact of this disease.
To achieve this vision, Prostate Cancer Research Inc has set six core goals. The first goal is to establish itself as a leader in prostate cancer research, showcasing its expertise and dedication to this cause. The second goal is to enhance its credibility and reputation within the research community, ensuring that its work is recognized and respected.
The organization seeks to establish partnerships and bridge connections between various sectors affected by prostate cancer, including the scientific community, government, the pharmaceutical industry, and those directly impacted by the disease. This collaborative approach aims to pool resources and knowledge, accelerating the pace of research and the development of new treatments.
Moreover, Prostate Cancer Research Inc is committed to assembling a team of experts in all aspects of running a successful and robust research charity. This includes individuals with expertise in fundraising, research, and community engagement. The organization also fosters a culture of continuous learning, encouraging its team to grow and adapt in their pursuit of new breakthroughs.
Lastly, Prostate Cancer Research Inc aims to sustain its growth through a dual approach. This involves bidding for larger grants to secure significant funding, while also strategically investing its funds to build flexible funding sources. This approach ensures the organization's long-term sustainability, allowing it to continue its mission of pioneering prostate cancer research and treatment.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
Prostate Cancer Research Inc is dedicated to combating prostate cancer through innovative research and development of breakthrough treatments. Since its inception, the organization has focused on two primary areas: enhancing the classification of advanced prostate cancer and discovering new treatment options.
By improving the classification systems for advanced prostate cancer, the organization aims to tailor treatment strategies to individual patients, ensuring that therapies are selected based on specific subtypes of the disease. This personalized approach not only seeks to optimize treatment efficacy but also empowers patients by providing clearer insights into their unique cancer profiles.
Additionally, Prostate Cancer Research Inc is committed to discovering novel therapies designed to contain cancerous cells within the prostate and prevent progression to advanced stages. This proactive stance is essential for improving patient outcomes and potentially reducing the burden of advanced prostate cancer.
Prostate Cancer Research Inc is also focused on establishing credibility and fostering collaboration among researchers, pharmaceutical companies, and individuals affected by prostate cancer. This network-building is integral to advancing research efforts and ensuring that findings translate into effective treatments.
With a commitment to continuous learning and sustainable growth, the organization aims to become the gold standard in prostate cancer research. By pursuing larger grants and making strategic investments, Prostate Cancer Research Inc is positioned to make a significant impact in the fight against prostate cancer, ultimately striving for a world where individuals are free from its effects.
This information is meant to be a general summary of Prostate Cancer Research Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Gross Receipts: $22,687
Assets and Liabilities:
- Total Assets: $29,232
- Total Liabilities: $354,216
- Net Assets: -$324,984
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2020
Principal Officer
John Wetherington
Website
www.pcrus.orgNTEE Category
Code: H40 - Medical research
If you are a representative of Prostate Cancer Research Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.